
CurePharma develops and manufactures pharmaceutical and nutraceutical products to address modern health challenges. The company operates as an MHRA‑licensed facility offering CDMO services and global manufacturing capabilities. Core technologies include advanced manufacturing with AI integration and regulatory‑compliant CTD dossier preparation. It serves markets in the UK, EU, Middle East, and Africa from MHRA‑GMP approved facilities. The business model combines CDMO, manufacturing, and distribution for business customers.

CurePharma develops and manufactures pharmaceutical and nutraceutical products to address modern health challenges. The company operates as an MHRA‑licensed facility offering CDMO services and global manufacturing capabilities. Core technologies include advanced manufacturing with AI integration and regulatory‑compliant CTD dossier preparation. It serves markets in the UK, EU, Middle East, and Africa from MHRA‑GMP approved facilities. The business model combines CDMO, manufacturing, and distribution for business customers.